PIPA522248

BTLA Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA522248-Each-of-1 In Stock ₹ 49,439.50

PIPA522248 - Each of 1

₹ 49,439.50

In Stock

Quantity

1

Base Price: ₹ 49,439.50

GST (18%): ₹ 8,899.11

Total Price: ₹ 58,338.61

Antigen

BTLA

Classification

Polyclonal

Conjugate

Unconjugated

Gene

BTLA

Gene Alias

A630002H24; B and T lymphocyte associated; B and T lymphocyte associated protein; B and T lymphocyte attenuator; B- and T-lymphocyte attenuator; B- and T-lymphocyte-associated protein; BTLA; BTLA_HUMAN; BTLA1; CD272; CD272 antigen; FLJ16065; MGC129743

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

151888

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Applications

Immunohistochemistry (Paraffin), Western Blot

Concentration

1 mg/mL

Formulation

0.1M tris glycine with 10% glycerol and 0.01% thimerosal; pH 7

Gene Accession No.

Q7Z6A9

Gene Symbols

BTLA

Immunogen

Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 164 of CD272

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA531719

--

Img

Thermo Scientific

PIPA527701

--

Img

Thermo Scientific

PIPA528378

--

Img

Thermo Scientific

PIPA531721

--

Img

Thermo Scientific

PIPA521940

--

Img

Thermo Scientific

PIPA556661

--

Img

Thermo Scientific

PIPA522055

--

Img

Thermo Scientific

PIPA557510

--

Description

  • Recommended positive controls: A375
  • Store product as a concentrated solution
  • Centrifuge briefly prior to opening the vial
  • BTLA or B and T-lymphocyte attenuator is a member of the co-inhibitory receptors of the CD28 superfamily
  • BTLA is a lymphocyte inhibitory receptor which inhibits lymphocytes during immunes responses
  • BTLA is constitutively expressed on most CD4+ and CD8+ T cells and its expression progressively decreases upon T cell activation
  • It remains expressed on Th1 cells, but not Th2 cells
  • BTLA is a unique co-receptor that interacts with the tumor necrosis factor receptor superfamily member herpesvirus entry mediator (HVEM)
  • This interation is an important pathway regulating lymphocyte activation and/or homeostasis in the immune response.